• Markets
    • icon
  • Companies
IMR · ASX

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:IMR)

AU$0.56

 -0.005 (-0.877%)
ASX:Live
06/12/2023 04:10:05 PM
HALO Ords HALO Capital Efficiency GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IMR Overview

IMR Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IMR

Website

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Telephone

1.952.818.8400

Address

400 Gateway Boulevard Burnsville, MN 55337

Description

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The firm offers the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator, Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter, and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was founded by Steven Wedan in 2006 and is headquartered in Burnsville, MN.

IMR Price Chart

Key Stats

Market Cap

AU$93.75M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.18 - 0.83

Trade Value (12mth)

AU$14,339.00

1 week

-2.59%

1 month

-5.83%

YTD

56.94%

1 year

46.75%

All time high

2.94

Key Fundamentals

EPS 3 yr Growth

-16.400%

EBITDA Margin

%

Operating Cashflow

-$24m

Free Cash Flow Return

-97.50%

ROIC

-102.50%

Interest Coverage

-93.00

Quick Ratio

3.60

Other Data

Shares on Issue (Fully Dilluted)

151m

HALO Sector

Healthcare

Next Company Report Date

21-Feb-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IMR Announcements

Latest Announcements

Date Announcements

31 October 23

Imricor Q3 FY23 Quarterley Activities Report and Appendix 4C

×

Imricor Q3 FY23 Quarterley Activities Report and Appendix 4C

31 August 22

Appendix 4D and Half Year Report & Accounts

×

Appendix 4D and Half Year Report & Accounts

31 August 22

Imricor releases Half Year Results for 1H 2022

×

Imricor releases Half Year Results for 1H 2022

31 August 22

H1 FY22 Results Investor Presentation

×

H1 FY22 Results Investor Presentation

29 September 23

Funding Facility Drawdown

×

Funding Facility Drawdown

29 September 23

Proposed issue of securities - IMR

×

Proposed issue of securities - IMR

29 March 23

Notification regarding unquoted securities - IMR

×

Notification regarding unquoted securities - IMR

29 August 23

Becoming a substantial holder

×

Becoming a substantial holder

29 April 22

Imricor to Present at NWR Virtual Conference

×

Imricor to Present at NWR Virtual Conference

28 September 23

Change of Registered Address in Australia

×

Change of Registered Address in Australia

28 November 23

Joint Development Agreement with ADIS for AI Modules

×

Joint Development Agreement with ADIS for AI Modules

28 March 22

Change of Director's Interest Notice

×

Change of Director's Interest Notice

28 June 22

Imricor Signs Siemens Agreements and Businss Update

×

Imricor Signs Siemens Agreements and Businss Update

28 June 22

Change in substantial holding

×

Change in substantial holding

28 July 22

Appendix 4C - Quarterly Report and Business Update

×

Appendix 4C - Quarterly Report and Business Update

28 January 22

Details of FY21 Results Investor Briefing

×

Details of FY21 Results Investor Briefing

28 April 22

Updated Corporate Goverance Statement

×

Updated Corporate Goverance Statement

28 April 22

Appendix 4C - Quarterly Report and Business Update

×

Appendix 4C - Quarterly Report and Business Update

27 October 22

Imricor Q3 FY22 Quarterley Activities Report and Appendix 4C

×

Imricor Q3 FY22 Quarterley Activities Report and Appendix 4C

27 October 22

Investor Presentation

×

Investor Presentation

27 July 23

Imricor Q2 FY23 Quarterley Activities Report and Appendix 4C

×

Imricor Q2 FY23 Quarterley Activities Report and Appendix 4C

27 January 23

Imricor and GE HealthCare MOU for Collaboration

×

Imricor and GE HealthCare MOU for Collaboration

27 January 22

Appendix 4C - Quarterly Report and Business Update

×

Appendix 4C - Quarterly Report and Business Update

27 April 23

Imricor Q1 FY23 Quarterley Activities Report and Appendix 4C

×

Imricor Q1 FY23 Quarterley Activities Report and Appendix 4C

26 September 23

Approval to Commence VISABL-VT Trial in Germany

×

Approval to Commence VISABL-VT Trial in Germany

26 November 20

Imricor to Present at Bell Potter Healthcare Conference

×

Imricor to Present at Bell Potter Healthcare Conference

26 May 23

Release from Voluntary Escrow

×

Release from Voluntary Escrow

IMR Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.16 -0.20 -0.17 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.16 -0.20 -0.17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.1 -22.4 14.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.13 -0.16 -0.15 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.17 -0.18 -0.17 Lock Lock Lock
     Growth % Lock Lock Lock Lock -34.5 -26.1 6.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.6 -18.4 -45.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.30 0.22 0.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.29 0.22 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock 194.7 -26.9 -66.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 110 131 146 Lock Lock Lock
Basic m Lock Lock Lock Lock 110 131 146 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.8 -9.0 26.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 17 24 23 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -253.0 -337.3 12.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -56.6 -272.3 -187.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 157 372 287 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -17 -26 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -83.4 -57.1 8.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,627.6 -2,810.7 -2,027.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -17 -27 -25 Lock Lock Lock
     Growth % Lock Lock Lock Lock -84.3 -55.4 7.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,702.8 -2,909.7 -2,115.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -18 -26 -25 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -18 -26 -25 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.5 -45.4 4.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,772.6 -2,834.0 -2,127.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -18 -23 -24 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -1 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 48 15 6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -19 -24 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -87.3 -28.1 -0.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -18.5 -26.0 -20.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 33 25 8 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 44 37 20 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 2 5 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -29 -23 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 6 9 Lock Lock Lock
Equity $m Lock Lock Lock Lock 37 31 11 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 40 32 16 Lock Lock Lock
     Growth % Lock Lock Lock Lock 228.3 -18.2 -49.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -41.6 -71.2 -123.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -48.4 -85.3 -226.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -65.1 -73.2 -98.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -69.8 -72.8 -102.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -68.6 -64.5 -97.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -38.0 -179.8 -93.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.8 0.9 0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -78.6 -74.9 -16.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 12.6 8.3 4.7 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 11.2 7.4 3.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 86.9 81.6 58.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -596.2 -619.4 -778.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.1 4.4 7.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.6 0.9 1.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 67.2 101.8 32.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -1,772.6 -2,834.0 -2,127.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -41.6 -71.2 -123.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -41.6 -71.2 -123.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -48.4 -85.3 -226.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -48.4 -85.3 -226.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 652.8 398.0 373.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 117.0 82.5 48.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 769.8 480.5 422.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 69.2 98.3 76.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 700.7 382.2 346.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IMR Shortsell

Frequently Asked Questions

The current share price of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$0.56.
The 52-week high share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is AU$0.83.
The 52-week low share price for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX)? is AU$0.18.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) does not pay a dividend.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) has a franking level of 0%.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is classified in the Healthcare.
The current P/E ratio for Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.